Provided by Tiger Trade Technology Pte. Ltd.

Alpha Tau Medical

14.11
-0.5300-3.62%
Post-market: 14.10-0.0100-0.07%19:39 EDT
Volume:3.12M
Turnover:44.20M
Market Cap:1.30B
PE:-13.42
High:15.00
Open:14.69
Low:14.05
Close:14.64
52wk High:15.10
52wk Low:3.35
Shares:92.33M
Float Shares:63.79M
Volume Ratio:6.57
T/O Rate:4.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0517
EPS(LYR):-0.5300
ROE:-141.68%
ROA:-25.71%
PB:29.57
PE(LYR):-26.62

Loading ...

Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.

TIPRANKS
·
Jun 24

Alpha Tau treats first recurrent glioblastoma patient in Israel with Alpha DaRT under broad-access study

Reuters
·
Jun 23

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 13

Alpha Tau Medical Says FDA Clears Additional Patients, Sites for Alpha DaRT Trial in Glioblastoma

MT Newswires Live
·
Jun 11

Alpha Tau Receives FDA Clearance to Complete Enrollment in Regain Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control

THOMSON REUTERS
·
Jun 11

Alpha Tau Medical - to Resume Recruitment for Remaining Seven Patients in Regain Trial

THOMSON REUTERS
·
Jun 11

Alpha Tau Medical - FDA Authorizes Two Additional U.S. Cancer Centers to Join Regain Trial

THOMSON REUTERS
·
Jun 11

Top Executive Makes Major Move With Alpha Tau Medical Stock

TIPRANKS
·
Jun 05

Alpha Tau Medical CFO Raphi Levy disposes of $352,606 in common shares

Reuters
·
Jun 05

Alpha Tau Medical Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 04

Alpha Tau Medical Is Maintained at Overweight by Barclays

Dow Jones
·
Jun 04

Alpha Tau Medical Ltd (DRTS) Receives a Buy from Barclays

TIPRANKS
·
Jun 04

Alpha Tau, Tolmar announce strategic collaboration agreement

TIPRANKS
·
Jun 03

Alpha Tau Medical, Tolmar International Agree to Develop, Commercialize Prostate Cancer Therapy

MT Newswires Live
·
Jun 03

Alpha Tau, Tolmar partner to develop, commercialize Alpha DaRT for U.S. prostate cancer patients

Reuters
·
Jun 03

Alpha Tau Medical - Tolmar Granted Exclusive U.S. Rights for Prostate Cancer, Option for Bladder Cancer

THOMSON REUTERS
·
Jun 03

Alpha Tau Medical - Tolmar to Invest $15M in Manufacturing, $20M Equity at $11.99/Share, up to $161.5M in Milestones

THOMSON REUTERS
·
Jun 03

Alpha Tau Medical - to Manufacture Alpha Dart for Tolmar at 60% of Net Sales Price

THOMSON REUTERS
·
Jun 03

Alpha Tau Medical - up to $96.5M in Development and $65M in Commercial Milestone Payments Agreed

THOMSON REUTERS
·
Jun 03

Alpha Tau Medical Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 03